Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-88644-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823862226755256320 |
|---|---|
| author | Methi Wathikthinnakon Piriya Luangwattananun Nunghathai Sawasdee Chutipa Chiawpanit Vannajan Sanghiran Lee Piyarat Nimmanpipug Yingmanee Tragoolpua Siriphorn Rotarayanont Thanich Sangsuwannukul Nattaporn Phanthaphol Yupanun Wutti‑in Chalermchai Somboonpatarakun Thaweesak Chieochansin Mutita Junking Jatuporn Sujjitjoon Pa‑thai Yenchitsomanus Aussara Panya |
| author_facet | Methi Wathikthinnakon Piriya Luangwattananun Nunghathai Sawasdee Chutipa Chiawpanit Vannajan Sanghiran Lee Piyarat Nimmanpipug Yingmanee Tragoolpua Siriphorn Rotarayanont Thanich Sangsuwannukul Nattaporn Phanthaphol Yupanun Wutti‑in Chalermchai Somboonpatarakun Thaweesak Chieochansin Mutita Junking Jatuporn Sujjitjoon Pa‑thai Yenchitsomanus Aussara Panya |
| author_sort | Methi Wathikthinnakon |
| collection | DOAJ |
| format | Article |
| id | doaj-art-b5731009c2694cee830168d9721161d2 |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-b5731009c2694cee830168d9721161d22025-02-09T12:36:54ZengNature PortfolioScientific Reports2045-23222025-02-011511110.1038/s41598-025-88644-7Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cellsMethi Wathikthinnakon0Piriya Luangwattananun1Nunghathai Sawasdee2Chutipa Chiawpanit3Vannajan Sanghiran Lee4Piyarat Nimmanpipug5Yingmanee Tragoolpua6Siriphorn Rotarayanont7Thanich Sangsuwannukul8Nattaporn Phanthaphol9Yupanun Wutti‑in10Chalermchai Somboonpatarakun11Thaweesak Chieochansin12Mutita Junking13Jatuporn Sujjitjoon14Pa‑thai Yenchitsomanus15Aussara Panya16Doctoral Program in Biology, Faculty of Science, Chiang Mai UniversityDivision of Molecular Medicine, Department of Research and Development, Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol UniversityDivision of Molecular Medicine, Department of Research and Development, Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol UniversityDoctoral Program in Biology, Faculty of Science, Chiang Mai UniversityDepartment of Chemistry, Faculty of Science, University of MalayaDepartment of Chemistry, Faculty of Science, Chiang Mai UniversityDepartment of Biology, Faculty of Science, Chiang Mai UniversityDepartment of Biology, Faculty of Science, Chiang Mai UniversityDivision of Molecular Medicine, Department of Research and Development, Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol UniversityDivision of Molecular Medicine, Department of Research and Development, Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol UniversityDivision of Molecular Medicine, Department of Research and Development, Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol UniversityDivision of Molecular Medicine, Department of Research and Development, Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol UniversityDivision of Molecular Medicine, Department of Research and Development, Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol UniversityDivision of Molecular Medicine, Department of Research and Development, Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol UniversityDivision of Molecular Medicine, Department of Research and Development, Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol UniversityDivision of Molecular Medicine, Department of Research and Development, Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol UniversityDepartment of Biology, Faculty of Science, Chiang Mai Universityhttps://doi.org/10.1038/s41598-025-88644-7 |
| spellingShingle | Methi Wathikthinnakon Piriya Luangwattananun Nunghathai Sawasdee Chutipa Chiawpanit Vannajan Sanghiran Lee Piyarat Nimmanpipug Yingmanee Tragoolpua Siriphorn Rotarayanont Thanich Sangsuwannukul Nattaporn Phanthaphol Yupanun Wutti‑in Chalermchai Somboonpatarakun Thaweesak Chieochansin Mutita Junking Jatuporn Sujjitjoon Pa‑thai Yenchitsomanus Aussara Panya Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells Scientific Reports |
| title | Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells |
| title_full | Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells |
| title_fullStr | Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells |
| title_full_unstemmed | Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells |
| title_short | Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells |
| title_sort | author correction combination gemcitabine and pd l1xcd3 bispecific t cell engager bite enhances t lymphocyte cytotoxicity against cholangiocarcinoma cells |
| url | https://doi.org/10.1038/s41598-025-88644-7 |
| work_keys_str_mv | AT methiwathikthinnakon authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT piriyaluangwattananun authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT nunghathaisawasdee authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT chutipachiawpanit authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT vannajansanghiranlee authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT piyaratnimmanpipug authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT yingmaneetragoolpua authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT siriphornrotarayanont authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT thanichsangsuwannukul authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT nattapornphanthaphol authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT yupanunwuttiin authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT chalermchaisomboonpatarakun authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT thaweesakchieochansin authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT mutitajunking authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT jatupornsujjitjoon authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT pathaiyenchitsomanus authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells AT aussarapanya authorcorrectioncombinationgemcitabineandpdl1xcd3bispecifictcellengagerbiteenhancestlymphocytecytotoxicityagainstcholangiocarcinomacells |